Allogene Therapeutics Stock Forecast - Price Action Indicator
| ALLO Stock | USD 2.19 0.02 0.92% |
Allogene Stock Forecast is based on your current time horizon. Although Allogene Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Allogene Therapeutics' systematic risk associated with finding meaningful patterns of Allogene Therapeutics fundamentals over time.
Allogene |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.11 | 0.055 |
| Check Allogene Therapeutics Volatility | Backtest Allogene Therapeutics | Trend Details |
Allogene Therapeutics Trading Date Momentum
| On December 18 2024 Allogene Therapeutics was traded for 1.91 at the closing time. The top price for the day was 2.12 and the lowest listed price was 1.86 . The trading volume for the day was 2.8 M. The trading history from December 18, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.73% . The overall trading delta against the current closing price is 10.63% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Allogene Therapeutics to competition |
Other Forecasting Options for Allogene Therapeutics
For every potential investor in Allogene, whether a beginner or expert, Allogene Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Allogene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Allogene. Basic forecasting techniques help filter out the noise by identifying Allogene Therapeutics' price trends.View Allogene Therapeutics Related Equities
| Risk & Return | Correlation |
Allogene Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Allogene Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Allogene Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Allogene Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Allogene Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Allogene Therapeutics shares will generate the highest return on investment. By undertsting and applying Allogene Therapeutics stock market strength indicators, traders can identify Allogene Therapeutics entry and exit signals to maximize returns.
Allogene Therapeutics Risk Indicators
The analysis of Allogene Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Allogene Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting allogene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.22 | |||
| Standard Deviation | 5.09 | |||
| Variance | 25.96 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Allogene Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allogene Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Allogene Stock
Moving against Allogene Stock
| 0.72 | DRTS | Alpha Tau Medical | PairCorr |
| 0.67 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.63 | VCEL | Vericel Corp Ord | PairCorr |
| 0.62 | VCYT | Veracyte | PairCorr |
| 0.61 | DMAC | DiaMedica Therapeutics | PairCorr |
The ability to find closely correlated positions to Allogene Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allogene Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allogene Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allogene Therapeutics to buy it.
The correlation of Allogene Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allogene Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allogene Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allogene Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Allogene Therapeutics to cross-verify your projections. To learn how to invest in Allogene Stock, please use our How to Invest in Allogene Therapeutics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allogene Therapeutics. If investors know Allogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allogene Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.55) | Quarterly Revenue Growth (0.27) | Return On Assets (0.26) | Return On Equity (0.54) |
The market value of Allogene Therapeutics is measured differently than its book value, which is the value of Allogene that is recorded on the company's balance sheet. Investors also form their own opinion of Allogene Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allogene Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allogene Therapeutics' market value can be influenced by many factors that don't directly affect Allogene Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allogene Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allogene Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allogene Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.